Premenstrual syndrome. Evidence-based treatment in family practice.

S Douglas - Canadian family physician, 2002 - cfp.ca
OBJECTIVE To evaluate the strength of evidence for treatments for premenstrual syndrome
(PMS) and to derive a set of practical guidelines for managing PMS in family practice …

What is there to know about the effects of progestins on the human brain and cognition?

R Griksiene, R Monciunskaite, O Ruksenas - Frontiers in …, 2022 - Elsevier
Progestins are an important component of hormonal contraceptives (HCs) and hormone
replacement therapies (HRTs). Despite an increasing number of studies elucidating the …

Pharmacokinetic and behavioral effects of allopregnanolone in healthy women

E Timby, M Balgård, S Nyberg, O Spigset… - …, 2006 - Springer
Rationale The behavioral effects of allopregnanolone (3α-hydroxy-5α-pregnan-20-one) in
women are not known. Objective Allopregnanolone, a neuroactive steroid secreted by the …

[图书][B] Psychologie v medicíně

A Susan - 2015 - books.google.com
Souborná učebnice, první svého druhu, zahrnuje všechny obory psychologie, které
nezbytně potřebuje znát každý student lékařské fakulty. Publikace je jedinečná propojením …

Management strategies for premenstrual syndrome/premenstrual dysphoric disorder

CI Jarvis, AM Lynch, AK Morin - Annals of Pharmacotherapy, 2008 - journals.sagepub.com
Objective: To evaluate the current nonpharmacologic and pharmacologic treatment options
for symptoms of premenstrual syndrome (PMS) and premenstrual dysphoric disorder …

Premenstrual dysphoric disorder: recognition and treatment

EW Freeman, SJ Sondheimer - Primary care companion to …, 2003 - legacy.psychiatrist.com
Premenstrual dysphoric disorder (PMDD) represents the more severe and disabling end of
the spectrum of premenstrual syndrome and occurs in an estimated 2% to 9% of …

Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?

U Halbreich, PMS O'Brien, E Eriksson, T Bäckström… - CNS drugs, 2006 - Springer
Current evidence suggests that the accepted treatments for premenstrual syndrome
(PMS)/premenstrual dysphoric disorder (PMDD) have similar overall efficacy. While these …

Diagnosing and treating premenstrual syndrome in five western nations

G Weisz, L Knaapen - Social science & medicine, 2009 - Elsevier
Premenstrual syndrome (PMS) and its derivative Premenstrual Dysphoric Disorder (PMDD)
are controversial medical diagnoses. On one hand they are ubiquitous in English-language …

Diagnosis and management of premenstrual disorders

S O'Brien, A Rapkin, L Dennerstein, T Nevatte - Bmj, 2011 - bmj.com
Premenstrual disorders have a substantial social, occupational, academic, and
psychological effect on the lives of millions of women (from menarche to menopause) and …

Higher luteal progesterone is associated with low levels of premenstrual aggressive behavior and fatigue

A Ziomkiewicz, B Pawlowski, PT Ellison, SF Lipson… - Biological …, 2012 - Elsevier
Contradictory findings show both positive and negative effect of progesterone on the
premenstrual mood changes in women. Here we present the study investigating this …